TY - JOUR
T1 - Mildly elevated homocysteine concentrations impair endothelium dependent vasodilation in hypercholesterolemic patients
AU - Schlaich, Markus P.
AU - John, Stefan
AU - Jacobi, Johannes
AU - Lackner, Karl J.
AU - Schmieder, Roland E.
PY - 2000/12
Y1 - 2000/12
N2 - Background: Elevated low density lipoproteins (LDL)-cholesterol and homocysteine levels have both been found to be associated with an increased risk for atherosclerotic vascular disease. To assess the effects of elevated homocysteine levels in hypercholesterolemic subjects on endothelial function, we examined basal and stimulated nitric oxide (NO) mediated vasodilation in the forearm vascular bed in hypercholesterolemic subjects with normal or elevated homocysteine levels. Methods: Twenty-seven white subjects (age: 48 ± 12 years) with elevated LDL-cholesterol (≥ 160 mg/dl) were divided into two groups with normal (n = 11) or mildly elevated (n = 16) homocysteine plasma concentration. We used strain gauge plethysmography to measure changes in forearm blood flow in response to intraarterial administration of increasing doses of acetylcholine (3, 12, 24, 48 μg/min), sodium nitroprusside (200, 800, 3200 ng/min), and N-monomethyl L-arginine (L-NMMA) (1, 2, 4 μmol/min). Total homocysteine plasma concentrations were determined by high performance liquid chromatography fluorimetry. Results: Endothelium independent vascular relaxation tested by i.a. sodium nitroprusside and changes in forearm blood flow after i.a. L-NMMA indicating basal production and release of nitric oxide were similar between the two groups with normal or elevated homocysteine levels. In contrast, endothelium dependent vasodilation as assessed by the administration of i.a. acetylcholine differed between the groups with normal or elevated homocysteine levels for all doses tested (MANOVA P < 0.01: ACH 48 μg/min: 480 ± 237% with normal vs 234 ± 130% with elevated homocysteine; P < 0.002). This was significant even after taking possible covariates such as age, blood pressure, body mass index, LDL-, high density lipoproteins (HDL)-cholesterol, and trigylcerides into account (MANOVA P < 0.02). Conclusions: From our study we conclude that homocysteine impairs endothelium dependent vasodilation in subjects with elevated LDL-cholesterol levels. The most intriguing finding is that even mildly elevated homocysteine levels seem to be of crucial importance for deterioration of endothelial function, especially if other cardiovascular risk factors such as hypercholesterolemia preexist.
AB - Background: Elevated low density lipoproteins (LDL)-cholesterol and homocysteine levels have both been found to be associated with an increased risk for atherosclerotic vascular disease. To assess the effects of elevated homocysteine levels in hypercholesterolemic subjects on endothelial function, we examined basal and stimulated nitric oxide (NO) mediated vasodilation in the forearm vascular bed in hypercholesterolemic subjects with normal or elevated homocysteine levels. Methods: Twenty-seven white subjects (age: 48 ± 12 years) with elevated LDL-cholesterol (≥ 160 mg/dl) were divided into two groups with normal (n = 11) or mildly elevated (n = 16) homocysteine plasma concentration. We used strain gauge plethysmography to measure changes in forearm blood flow in response to intraarterial administration of increasing doses of acetylcholine (3, 12, 24, 48 μg/min), sodium nitroprusside (200, 800, 3200 ng/min), and N-monomethyl L-arginine (L-NMMA) (1, 2, 4 μmol/min). Total homocysteine plasma concentrations were determined by high performance liquid chromatography fluorimetry. Results: Endothelium independent vascular relaxation tested by i.a. sodium nitroprusside and changes in forearm blood flow after i.a. L-NMMA indicating basal production and release of nitric oxide were similar between the two groups with normal or elevated homocysteine levels. In contrast, endothelium dependent vasodilation as assessed by the administration of i.a. acetylcholine differed between the groups with normal or elevated homocysteine levels for all doses tested (MANOVA P < 0.01: ACH 48 μg/min: 480 ± 237% with normal vs 234 ± 130% with elevated homocysteine; P < 0.002). This was significant even after taking possible covariates such as age, blood pressure, body mass index, LDL-, high density lipoproteins (HDL)-cholesterol, and trigylcerides into account (MANOVA P < 0.02). Conclusions: From our study we conclude that homocysteine impairs endothelium dependent vasodilation in subjects with elevated LDL-cholesterol levels. The most intriguing finding is that even mildly elevated homocysteine levels seem to be of crucial importance for deterioration of endothelial function, especially if other cardiovascular risk factors such as hypercholesterolemia preexist.
KW - Atherosclerosis
KW - Endothelium
KW - Foreram blood flow
KW - Homocysteine
KW - Hypercholesterolemia
KW - Lipids
KW - Nitric oxide
UR - http://www.scopus.com/inward/record.url?scp=0034509311&partnerID=8YFLogxK
U2 - 10.1016/S0021-9150(00)00412-3
DO - 10.1016/S0021-9150(00)00412-3
M3 - Article
C2 - 11164427
AN - SCOPUS:0034509311
SN - 0021-9150
VL - 153
SP - 383
EP - 389
JO - Atherosclerosis
JF - Atherosclerosis
IS - 2
ER -